Back
Compagnie de Saint-Gobain SA Vs. MiNK Therapeutics, Inc. Industry Stock Comparison
Buy
59
CODGF
Compagnie de Saint-Gobain SA
Last Price:
$99.50
Seasonality Move:
1.15%
Sell
30
INKT
MiNK Therapeutics, Inc.
Last Price:
$11.72
Seasonality Move:
-20.14%
Buy
59
Compagnie de Saint-Gobain SA (CODGF)
is a Buy
Is Compagnie de Saint-Gobain SA a Buy, Sell or Hold?
-
The current Compagnie de Saint-Gobain SA [CODGF] share price is $100.30. The Score for CODGF is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
CODGF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?
-
The current MiNK Therapeutics, Inc. [INKT] share price is $11.50. The Score for INKT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
INKT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CODGF Stock Price Chart
What is Compagnie de Saint-Gobain SA's stock price today?
-
The Compagnie de Saint-Gobain SA share price today is $100.30Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CODGF is experiencing slight buying pressure.
INKT Stock Price Chart
What is MiNK Therapeutics, Inc.'s stock price today?
-
The MiNK Therapeutics, Inc. share price today is $11.50Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing selling pressure, which indicates risk of future bearish movement.
CODGF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.13 | Sell |
| Relative Strength Index (14 RSI): | 63.03 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (92.38 - 95.86) | Buy |
| Bollinger Bands (100): | (97.76 - 114.12) | Sell |
INKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.63 | Sell |
| Relative Strength Index (14 RSI): | 45.24 | Sell |
| Chaikin Money Flow: | -20001 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.92 - 13.34) | Sell |
| Bollinger Bands (100): | (12.18 - 16.64) | Sell |
CODGF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 94.14 | Buy |
| 20-day SMA: | 93.91 | Buy |
| 50-day SMA: | 99.34 | Buy |
| 200-day SMA: | 106.41 | Sell |
| 8-day EMA: | 94.9 | Buy |
| 20-day EMA: | 95.08 | Buy |
| 50-day EMA: | 98.71 | Buy |
| 200-day EMA: | 87.52 | Buy |
INKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.15 | Buy |
| 20-day SMA: | 11.81 | Sell |
| 50-day SMA: | 13.28 | Sell |
| 200-day SMA: | 11.74 | Sell |
| 8-day EMA: | 11.36 | Buy |
| 20-day EMA: | 11.8 | Sell |
| 50-day EMA: | 12.83 | Sell |
| 200-day EMA: | 12.22 | Sell |
Compagnie de Saint-Gobain SA Earnings Growth & CODGF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
Compagnie de Saint-Gobain SA Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MiNK Therapeutics, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||